• China Cancer Drug Market to reach US$ 35.24 Billion by 2027 - According to Renub Research latest report "China Oncology Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" China Cancer Drug Market is estimated to reach US$ 35.24 Billion by 2027. An estimated 9.6 million people died from cancer in 2018, making it the second highest cause of death worldwide. Approximately 1 in 6 deaths worldwide are attributed to cancer, according to figures released by the WHO. China, the most populated nation in the world, is experiencing a marked increase in cancer rates. According to the Global Cancer Observatory 2018, China has 4,285,033 new cancer cases yearly. After regulatory measures to streamline and encourage drug development, which also opened the way for increased investment by foreign pharmaceutical firms, China seems destined to become a major developer of cancer treatments within a few years. China cancer drug market will grow significantly with 6.84% CAGR during the forecast period 2022 to 2027: The growth of China cancer drug market is driven by rise in the incidence of various cancer conditions, an increase in the popularity of advanced therapies, ageing population, increased R&D investment, changing sedentary lifestyle, and westernized diet. Additionally, increased cancer awareness and cancer drug availability are anticipated to boost market expansion. Furthermore, an increase in pipeline products is expected to provide new prospects for market participants in the future. Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=china-cancer-drugs-market-p.php Targeted Therapy dominates the Market: Based on therapy, China cancer drug market is divided into Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal therapy. Targeted therapy holds the largest market share since targeted medicines have higher efficacy and survival rates as they can only eliminate malignant cells. Furthermore, Immunotherapy will also grow during the forecast period since immunotherapy medications may be harmless to the body's other living cells, making them less toxic than other cancer treatments. Lung Cancer and Breast Cancer hold a significant share by indication: By indication, the breast cancer category contributed a significant market share. Furthermore, it is projected that this trend will continue throughout the forecast period due to the hike in the number of people affected by the disease due to early detection. On the other hand, lung cancer is anticipated to experience the fastest market growth during the forecast period because of an increase in the geriatric population, changes in people's lifestyles, and an increase in tobacco use, including passive smoking, which can cause lung cancer. China Cancer Drug Market was US$ 23.70 Million in 2021 Due to the growth in the prevalence of severe cancer pain, the increased use of opioids in the treatment of cancer pain, and the significant presence of pipeline pharmaceuticals Opioids segment holds the significant market share. Furthermore, Anti-emetics and Bisphosphonates will grow during the forecast period due to the launch of more affordable generic alternatives and rise in investment by key players in these segments. Key Players Analysis: Bristol Myers Squibb, Merck, Eli Lilly, Sino BioPharma, F Hoffmann-La Roche AG, Johnson & Johnson, and Abbvie Inc. are the leading players in the surgical imaging market. These competitors are continuously adopting various strategies for increasing their market share. These include collaborations, product approval, development, and acquisition to expand their geographic reach. Covid-19 impact on China Cancer Drug Market: The coronavirus epidemic has significantly impacted all sectors of society. Consequently, the healthcare industry has been particularly affected, including cancer treatment and the development of new drugs. Throughout the pandemic, many clinical cancer experiments were halted in China. For patients with advanced cancer, some of these experimental medicines represented their final hope. Furthermore, the pandemic directly impacted the supply of oncology drugs to patients, due to which China cancer drug market declined. Remarkably, the pandemic negatively influenced China's oncology drugs industry, which depended on quick testing and diagnosis as well as prompt and coordinated multimodal treatment. However, the initial and long-lasting impacts of the COVID-19 pandemic on the use of cancer drugs diminished during the post-pandemic period in China. Therapy 1. Chemotherapy 2. Targeted Therapy 3. Immunotherapy (Biologic Therapy) 4. Hormonal Therapy Indication 1. Blood Cancer 2. Breast Cancer 3. Gastrointestinal Cancer 4. Prostate Cancer 5. Lung Cancer 6. Skin Cancer 7. Ovarian Cancer 8. Cervical Cancer 9. Kidney Cancer 10. Other Cancers Drugs 1. ESAs (Erythropoiesis Stimulating Agents) 2. G-CSFs (Granulocyte-colony Stimulating Factors) 3. Anti-emetics 4. Bisphosphonates 5. Opioids 6. NSAIDs & Others Key Players 1. Bristol Myers Squibb 2. Merck 3. Eli Lilly 4. Sino BioPharma 5. F Hoffmann-La Roche AG 6. Johnson & Johnson 7. Abbvie Inc. 8. AstraZeneca plc (Added: Tue Nov 15 2022 Hits: 36 Rating: 0.00 Votes: 0) Rate It

• National Nutrition Announces New Partnership with ATP Lab - ORILLIA, ON: October 26, 2022 - National Nutrition, Canada's largest online retailer of natural health supplements, has announced a new partnership with ATP Lab, a Canadian sports nutrition company making natural, pharmaceutical-grade sports nutrition products. This partnership with ATP Lab will see 64 new products added to National Nutrition's shelves and will be available both in-store and online. Pharmaceutical Grade, Lab Tested Sports Products ATP Lab produces quality sports nutrition products right here in Canada. Their commitment to quality has earned them respect in the fitness industry, and their products are often recommended by personal trainers. ATP Lab has formulated a unique protein powder, Supreme Beef Protein. This protein is sourced from beef bone broth and hydrolyzed bovine collagen. It’s a clean protein that is free of hormones and antibiotics. This protein is great for people who are looking to build lean muscle mass and reduce body fat. Supreme Beef Protein is a high-quality source of protein, making it a preferred choice among bodybuilders and athletes. The product is also gluten free and non-GMO. ATP Lab's IBCAA is a branched chain amino acid supplement that provides users with a quick energy source. It’s a great product if you are looking to build muscle mass or need an edge during your workout sessions. It dissolves instantly into water, making it a convenient way to supercharge workouts - whether at home or at the gym. ATP Lab products are all pharmaceutical grade and lab tested, making them a trusted choice among personal trainers. ATP Lab tests every raw material to identify its potency and purity, as well as for microbial contaminants, heavy metals, solvent residues and allergens. Herbal ingredients are tested for pesticide compounds. Plus, ATP Lab is putting ‘natural’ into sports nutrition and has championed the hashtag #ArtificialFree in their products. A Wider Selection of Products For Sport Since 1996, National Nutrition has been on a mission to offer the most effective products from top-shelf companies. Products that push the boundaries and help National Nutrition's customers meet their health and performance goals. Early on, National Nutrition recognized that movement and exercise is an important pillar of overall wellness and made an effort to stock more products that help support consumers on their fitness journey. This partnership will allow National Nutrition to offer a wider selection of sports nutrition products, including pre-workout and post-workout supplements, protein powders and more. National Nutrition customers can now shop for ATP Lab products either in-store or online, making it convenient to shop for your health. "At National Nutrition, we're committed to providing our customers with the highest quality products available," said National Nutrition president and CEO Darren Firth. "Our partnership with ATP Lab will provide our customer base more access to sports nutrition products that are both effective and safe." "We're thrilled to be working with National Nutrition," said Robert Légaré, President of ATP Lab. "Their reach and reputation make them an ideal partner for us." He continues, "We look forward to working with National Nutrition as our brand continues to grow." You can find ATP Lab full selections of products on ATP Lab brand page at National Nutrition.ca About National Nutrition National Nutrition has been customer-focused, which is why they are always expanding its line of products. They believe in empowering their customers with knowledge through articles, videos and recipes. They also ensure their team is made up of certified holistic nutritionists and naturopaths to better serve their customers. (Added: Tue Nov 15 2022 Hits: 49 Rating: 0.00 Votes: 0) Rate It

• The Best 12 Endoscopes Market Products, Period - Endoscopes Companies are segmented By Item Type( Rigid Endoscopes( Laparoscopes, Arthroscopes, Cystoscopes, Neuroendoscopes), Flexible Endoscopes( Upper gastrointestinal endoscopes( Colonoscopes, Bronchoscopes, Sigmoidoscopes)), Capsule Endoscopes, Disposable Endoscopes, Software Assisted Endoscopes), By Procedures( Gastrointestinal( GI) Endoscopy, Laparoscopes, Urology Endoscopy( Cystoscopy), Gynaecology Endoscopy, Arthroscopy, Bronchoscopy), By Consumer( Hospital, Portable Surgical Centres), and Area( The united states, Latin America, Europe, Asia Pacific, Middle East, and Africa)– Share, Size, Perspective, and Opportunity Analysis, 2022- 2029 Market Overview The Endoscopes Market is usually expected to grow at a higher CAGR of 7.1% during the forecasting period (2022-- 2029). Endoscopy is an activity to look at the inner body parts using a musical instrument known as a great endoscope. An endoscope is an excellent long, thin, flexible tube the truth that has a source of light and a camera at one end. Pictures of the interior body will undoubtedly be relayed to some tv displays. Endoscopy might be used to analyse unusual symptoms that help perform certain different types of surgery. It is likewise utilized to remove a little test of tissue for analysis. Download Free Sample: https://www.datamintelligence.com/download-sample/endoscopes-market Actual physical analysis A global Endoscopes marketplace is segmented into the United States, European countries, Asia Pacific, South America, the Middle East, and Africa. The United States are dominating the global Endoscopes market, due to the rising incidence of cancer in the US. As an example, based on the National Cancer Institute, in 2018, around 1, 735, 300 and fifty new cases of cancer in America and 609, 640 individuals will die from the disease. The increasing number of items launches in the American market is traveling the North American endoscopes marketplace. For instance, in July 2018, FUJIFILM Medical Systems U. H. A., Inc.,700 Series Endoscopes. Europe is the 2nd most significant market for endoscopes in 2018, because of the investment in Endoscopy Action Strategy, with the regulatory body. As an example, in March 2019, Scottish Authorities introduced the Endoscopy Action Strategy, and invested£ 6 million. The federal government Endoscopy Plan of action is designed for patients with suspected cancer, with all the investment the us government will provide you with new technologies, additional clinics, and further working out for staff. Ready times for patients with supposed cancer are going to be targeted in this sort of plan of action, which may expose new technologies, additional clinics, and further working out for staff. The launch of a recent endoscope in Europe can be driving the endoscopes market in the region. For example, in July 2016, PENTAX Medical introduced a new large-definition (HD) pulmonology endoscopy system in European marketplaces. The new DEFINA system on Pulmonology combines a state-- of- the art HIGH-DEFINITION processor with- check-out imaging technology and two extremely manoeuvrable HD bronchoscope. Marketplace Mechanics The increasing prevalence of cancer is normally boosting an international endoscopy marketplace, as endoscopy procedures, such because laryngoscopy, upper endoscopy, and colonoscopy, can be used in the analysis of cancer. Probably the most prevalent cancers are the cancer of the breast, chest, and bronchus cancer, prostate malignancy, colon and rectum cancer, cancer malignancy of the skin, bladder malignancy, non-Hodgkin lymphoma, renal and renal pelvis cancer, endometrial cancer, leukaemia, pancreatic cancer, thyroid gland cancer, and liver cancer. The number of new cases of cancer is 439. 2 every 100, 000 men and women per twelve months. How many cancer fatalities is 163. 5 per 75, 000 women and men each year within the U.S. Based on Cancer Research Circumstance. K., advantages when compared to 360, 000 new cancer instances in Britain every twelve months, that's almost 990 every single day time. The incidence rates for just about all cancers combined are projected to go up by 2% in the UK between 2014 and 2035, to 742 cases per 100, 000 people by 2035. In the United Kingdom, there have been used 183, 000 fresh cancer cases in males and around 177, 000 new malignancy cases in females, in 2015. Section Analysis Based on item type, a global market intended for endoscopes is broadly segmented because of rigid endoscopes, flexible endoscopes, tablet endoscopes, disposable endoscopes, and robot-aided endoscopes. Currently, flexible endoscopes medical data for a dominant share of the worldwide endoscopes market. The market is usually driven by flexible endoscopes include a positive impact due to the collaboration between companies to develop new flexible endoscopes. As an example, on July 2017, PENTAX collaborated with Shanghai Aohua Photoelectricity Endoscope Company., Ltd., to build up products in neuro-scientific flexible medical endoscopy. Moreover, on October 2017, AGA partnered with Apollo Endosurgery to outcomes of trans-oral endoscopic suturing procedures performed with the business's OverStitch system. Transoral, versatile endoscopic suturing is utilized and intended for the treatment of gastroesophageal reflux diseases. Increasing regulatory mortgage loan approvals for flexible endoscopes is 1 of the principal factor traveling the worldwide endoscopes market. For example, in May 2016, Endo Choice received FDA 510(k) clearance intended for its Orca sterile, single-use air, water, and suction valves made for Olympus 160, 180, and 190 flexible endoscopes, and also introduced its 3rd-- gen Fuse endoscopy system and Rescue Net retrieval device. Automatic robot-assisted endoscopes are showing considerable growth in 2018, due to multiple regulatory approvals recently. Intended for instance, in March 2018, Auris Health, received FDA clearance because of its Monarch robotic endoscopy platform. The Monarch system is a versatile robotic endoscopic platform that uses a controller-like user interface that allows the operating doctors to navigate the robotic endoscope through the periphery of the chest competitive analysis The main players include Olympus Corporation, Ethicon US, LLC, Fujifilm Holdings Company, Boston Scientific Corporation, Karl Storz GmbH& Co. KG, Stryker Corporation, PENTAX Medical, Medtronic, Incorporation., Richard Wolf GmbH, and Make Medical The majority of the key companies will be focusing on the R&D of complex products and are aiming for inorganic growth strategies to boost marketplace competitiveness. For instance, in 06 2018, PENTAX Medical, a top-rated company for diagnostic and restorative endoscopy solutions, entered into a great exclusive distribution agreement with CapsoVision for its CapsoCam Plus Tablet Endoscopy line of products. In November 2016, CapsoVision, Inc., received FDA 510(k) clearance intended for the CapsoCam Plus small intestinal capsule endoscope system. CapsoCam In addition is a technology that gives a novel 360º panoramic horizontal image of the small intestinal, utilized for the detection of little bowel abnormalities. About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com (Added: Mon Nov 14 2022 Hits: 36 Rating: 0.00 Votes: 0) Rate It

• Nicolan’s Healthcare Pvt Ltd Redefining The Necessities - By Nicolan Healthcare Pvt Ltd London Colney, United Kingdom, 14 Nov 2022 https://www.nicolan.net/ Nicolan Healthcare Pvt Ltd is amongst the top pharmaceutical companies that serve people worldwide. While serving a huge population, it becomes our duty to focus on the needful measures that improve the ailments more smoothly. Usually, the necessities have increased due to the occurrence of underlying conditions. We are focusing to ensure while accessing medical supplies, people do not have to wander and look for reliable yet genuine medicines. As mentioned, we are trying to focus on providing authentic therapies, we would like you to know those therapies are approved and meet the standards. We have different solutions and include anti-bacterial, anti-fungal, anti-infective, gastrointestinal, antihistamine, calcium, vitamins, and neuropsychiatrist remedies all under a single roof to improve the conditions. We focus on providing therapies that are suitable for people around the globe and ensure their health is taken care of. We do try to keep the minimal components that don’t confuse the with the treatments of those remedies. Looking for the right medicines is necessary and this is what we are doing. We conduct thorough and repeated research that allows us to blend with the standards of the countries where we serve. Medicines have become a core part of routine people. Also, certain tablets are designed in a manner that they’re exceptional and one needs to access them urgently. Nicolan Healthcare Pvt Ltd does mechanization to fill the needs of the pharmaceutical industry. We understand the urgency and focus to serve at the earliest by following the accurate and innovative method to meet the needs of the people. Follow us: https://www.youtube.com/channel/UC_RbBKhqDpG7jKuRd9_6KxQ https://www.facebook.com/nicolanhealthcareltd https://www.instagram.com/nicolanhealthcareltd https://twitter.com/nicolancare https://www.linkedin.com/company/nicolan-healthcare (Added: Mon Nov 14 2022 Hits: 74 Rating: 0.00 Votes: 0) Rate It

• Global Skin Boosters market report, market size, share, trends, analysis and forecast to 2028 - Stratistics MRC’s Global Skin Boosters Market value is expected to reach $1.96 billion growing at a CAGR of 11.3% during 2022-2028. Skin boosters are injections that endorse collagen structure and improve the skin's natural ability to self-heal. These boosters are vitamin, hyaluronic acid, and mineral micro-injections that are injected into the epidermis to renew, hydrate, and revitalize the skin for a natural shine. These can be used on the neck, face, hands, and neckline but do not contour or shape the facial structure. In addition, the desire for glass skin, which has a porcelain-like, light texture and is free of impurities and blemishes, has escalated the use of skin boosters. Browse complete “Skin Boosters Market” report with TOC @ https://www.strategymrc.com/report/skin-boosters-market By geography, Asia Pacific is projected to hold the largest market share during the forecast period, due to high-quality and cost-effective therapy, the presence of developing countries such as India, China, and Thailand, increasing emphasis on physical attributes in these developing nations, increased disposable income, and an increasing incidence rate of skin disorders such as psoriasis and atopic dermatitis. Moreover, aesthetic operations have long been popular in Asian countries. India has been identified as one of the fastest developing markets owing to the growing popularity of social media among teenagers and adults. Some of the key players profiled in the Skin Boosters Market include Bloomage Biotechnology Corporation Limited, Galderma, IBSA – Institute Biochemical SA (IBSA Derma), Teoxane SA, Merz Aesthetics, Filorga, Professional Derma SA, and Allergan Plc. Request a Sample of “Skin Boosters Market” @ https://www.strategymrc.com/report/skin-boosters-market Free Customization Offerings: All the customers of this report will be entitled to receive one of the following free customization options: ● Company Profiling ● Comprehensive profiling of additional market players (up to 3) ● SWOT Analysis of key players (up to 3) ● Regional Segmentation ● Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check) ● Competitive Benchmarking ● Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances For more information about this report visit https://www.strategymrc.com/report/skin-boosters-market Report Store: https://www.strategymrc.com/report-store Covid-19 reports: https://www.strategymrc.com/covid-19-impact-reports About Us: Stratistics MRC offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. Contact Us: Email: sales@strategymrc.com Organization: Stratistics Market Research Consulting Pvt Ltd Phone: +1-301-202-5929 Website: https://www.strategymrc.com (Added: Sat Nov 12 2022 Hits: 17 Rating: 0.00 Votes: 0) Rate It

• International Conference on Dermatology and Cosmetology - We are delighted to welcome all the experts on all parts of the world to explore the "International Conference on Dermatology and Cosmetology” scheduled to be held from May 18-19, 2023 in the city of Tokyo, Japan. International Conference on Dermatology and Cosmetology pledges an excellent field day to share latest technology and current discoveries in skin care treatment, cancer preventions and future of heathy skin and closely related fields. This two-day scientific conference will focus on new developments and trends in cosmetology, trichology, plastic surgery, ageing medicine where speakers will deliver a talk on keynote, plenary sessions, productive poster presentation, hands on workshops and exhibitions providing insights to the significance and advancement of dermatology and cosmetology. This meeting brings together a unique and international mix of large- and small-scale companies/industries, leading universities and research institutions, including researchers, scientists, academicians, healthcare professionals, doctors, dermatologists, cosmetologists, pharmacists, and industry leaders make the conference the ideal setting for exchanging knowledge, creating cross-industry partnerships, and assessing innovative innovations from around the world. Dermatology 2023 intends to explore advances in dermatology and cosmetology practice, healthcare management and education in relation to health disparities as well as a breadth of other topics. Japan dermatological market size stood at around 17.1 billion in 2021 and it is projected to grow at a CAGR of more than 1% during the forecast period. Dermatological therapeutics are expanding rapidly due to the rising prevalence of dermatological disorders and the rising levels of information surrounding disease progression, etiology, and potential treatments. (Added: Sat Nov 12 2022 Hits: 41 Rating: 0.00 Votes: 0) Rate It

• International Conference on Dermatology and Cosmetology - We are delighted to welcome all the experts on all parts of the world to explore the "International Conference on Dermatology and Cosmetology” scheduled to be held from May 18-19, 2023 in the city of Tokyo, Japan. International Conference on Dermatology and Cosmetology pledges an excellent field day to share latest technology and current discoveries in skin care treatment, cancer preventions and future of heathy skin and closely related fields. This two-day scientific conference will focus on new developments and trends in cosmetology, trichology, plastic surgery, ageing medicine where speakers will deliver a talk on keynote, plenary sessions, productive poster presentation, hands on workshops and exhibitions providing insights to the significance and advancement of dermatology and cosmetology. This meeting brings together a unique and international mix of large- and small-scale companies/industries, leading universities and research institutions, including researchers, scientists, academicians, healthcare professionals, doctors, dermatologists, cosmetologists, pharmacists, and industry leaders make the conference the ideal setting for exchanging knowledge, creating cross-industry partnerships, and assessing innovative innovations from around the world. Dermatology 2023 intends to explore advances in dermatology and cosmetology practice, healthcare management and education in relation to health disparities as well as a breadth of other topics. Japan dermatological market size stood at around 17.1 billion in 2021 and it is projected to grow at a CAGR of more than 1% during the forecast period. Dermatological therapeutics are expanding rapidly due to the rising prevalence of dermatological disorders and the rising levels of information surrounding disease progression, etiology, and potential treatments. (Added: Sat Nov 12 2022 Hits: 37 Rating: 0.00 Votes: 0) Rate It

• International Conference on Dermatology and Cosmetology - We are delighted to welcome all the experts on all parts of the world to explore the "International Conference on Dermatology and Cosmetology” scheduled to be held from May 18-19, 2023 in the city of Tokyo, Japan. International Conference on Dermatology and Cosmetology pledges an excellent field day to share latest technology and current discoveries in skin care treatment, cancer preventions and future of heathy skin and closely related fields. This two-day scientific conference will focus on new developments and trends in cosmetology, trichology, plastic surgery, ageing medicine where speakers will deliver a talk on keynote, plenary sessions, productive poster presentation, hands on workshops and exhibitions providing insights to the significance and advancement of dermatology and cosmetology. This meeting brings together a unique and international mix of large- and small-scale companies/industries, leading universities and research institutions, including researchers, scientists, academicians, healthcare professionals, doctors, dermatologists, cosmetologists, pharmacists, and industry leaders make the conference the ideal setting for exchanging knowledge, creating cross-industry partnerships, and assessing innovative innovations from around the world. Dermatology 2023 intends to explore advances in dermatology and cosmetology practice, healthcare management and education in relation to health disparities as well as a breadth of other topics. Japan dermatological market size stood at around 17.1 billion in 2021 and it is projected to grow at a CAGR of more than 1% during the forecast period. Dermatological therapeutics are expanding rapidly due to the rising prevalence of dermatological disorders and the rising levels of information surrounding disease progression, etiology, and potential treatments. (Added: Sat Nov 12 2022 Hits: 38 Rating: 0.00 Votes: 0) Rate It

• International Conference on Dermatology and Cosmetology - We are delighted to welcome all the experts on all parts of the world to explore the "International Conference on Dermatology and Cosmetology” scheduled to be held from May 18-19, 2023 in the city of Tokyo, Japan. International Conference on Dermatology and Cosmetology pledges an excellent field day to share latest technology and current discoveries in skin care treatment, cancer preventions and future of heathy skin and closely related fields. This two-day scientific conference will focus on new developments and trends in cosmetology, trichology, plastic surgery, ageing medicine where speakers will deliver a talk on keynote, plenary sessions, productive poster presentation, hands on workshops and exhibitions providing insights to the significance and advancement of dermatology and cosmetology. This meeting brings together a unique and international mix of large- and small-scale companies/industries, leading universities and research institutions, including researchers, scientists, academicians, healthcare professionals, doctors, dermatologists, cosmetologists, pharmacists, and industry leaders make the conference the ideal setting for exchanging knowledge, creating cross-industry partnerships, and assessing innovative innovations from around the world. Dermatology 2023 intends to explore advances in dermatology and cosmetology practice, healthcare management and education in relation to health disparities as well as a breadth of other topics. Japan dermatological market size stood at around 17.1 billion in 2021 and it is projected to grow at a CAGR of more than 1% during the forecast period. Dermatological therapeutics are expanding rapidly due to the rising prevalence of dermatological disorders and the rising levels of information surrounding disease progression, etiology, and potential treatments. (Added: Sat Nov 12 2022 Hits: 35 Rating: 0.00 Votes: 0) Rate It

• New Nordic’s Clinical Grade Products Now Available at National Nutrition - ORILLIA, ON: October 24, 2022 - National Nutrition, a leading Canadian retailer of supplements, is expanding its offerings of New Nordic supplements. New Nordic is a Swedish based natural health supplement company and offers clinical-grade supplements that are now available at National Nutrition in-store and online. Bringing Swedish Quality Supplements Across Canada New Nordic was founded in 1990 and has grown to become a leading natural health supplement brand in Scandinavia, and is carried in 36 countries. The company is committed to producing high-quality, clinically-proven supplements that are manufactured with strict quality standards. The company was named New Nordic to reflect its innovative business model, a commitment to craftsmanship, and a life intertwined with nature. With products that showcase the power of plant-based ingredients, consumers can count on New Nordic to help them achieve their health goals. New Nordic is well-known for Hair Gro, a hair growth formula that uses a unique blend of ingredients to promote healthy scalp and hair growth. Hair Gro is a clinically proven formula that has been shown to increase hair thickness, length and overall health. Hair Gro by New Nordic is the clinically proven hair growth supplement with a patented tocotrienol complex, shown to increase new hair growth and hair count. The company is also widely known for its range of vitamin supplements, which are available at National Nutrition. With this partnership, National Nutrition will now carry New Nordic's Ashwagandha and Apple Cider Gummies+, in addition to the company's exceptional line of supplements. A Commitment to Sourcing New and Innovative Products National Nutrition has long been committed to sourcing the most efficacious and innovative products for their customers. This new partnership will see the addition of two new vegan gummy products: Apple Cider Gummies+ and Ashwagandha Gummies. For centuries, apple cider vinegar has been used as a health-promoting supplement for everything from diabetes to high cholesterol and digestive complaints like acid reflux. New Nordic Apple Cider Gummies+ provide consumers with their daily dose of apple cider vinegar in a sugar-free apple flavoured gummy. Ashwagandha root is a strong adaptogen, which helps the body cope with external stresses for reduced stress and anxiety, greater calmness and increased energy. New Nordic's Ashwagandha Gummies contain 300 mg of a 10:1 root extract in a delicious peach mango flavour. New Nordic's philosophy is to provide high quality, natural products that are scientifically proven and have the potential to enhance the wellbeing of consumers. Many of New Nordic's supplements are packaged in blister packs, which help to maintain freshness of the product. " We value National Nutrition's commitment to providing great education. National Nutrition has always been a leader in offering their customers top-tier guidance and education on choosing the right natural health product for them," says Jennifer Soueida, Sales and Marketing Manager at New Nordic. "We understand how confusing this industry can be, and it so important to us when retailers go the extra mile in helping their customers understand concepts like clinical-grade and research-proven doses, and why these features make a more efficacious supplement." "We are very pleased to continue our partnership with New Nordic. Our partnership has been successful over the years, and we look forward to its continued success.", says Darren Firth, CEO of National Nutrition. "We look forward to continuing this relationship and providing our customers with the highest quality supplements." New Nordic's Ashwagandha and Apple Cider Gummies+ are now available at National Nutrition, both in-store and online and can be found on their New Nordic's supplements section. About National Nutrition National Nutrition dot CA is Canada’s industry-leading online vitamin & supplement store. They’ve received many awards from the Canadian Health Food Association for being Canada’s best natural health food store and have been customer-focused for over 25 years. Not only do they provide high-quality brands and supplements, but National Nutrition dot CA also empowers their customers with natural health knowledge by leading industry experts communicated through videos on its Youtube channel and health-related articles on its website. (Added: Sat Nov 12 2022 Hits: 53 Rating: 0.00 Votes: 0) Rate It

• New Era Diagnostics | One Stop Destination For All Your Health Checks - Lorem ipsum dolor sit amet consectetur adipisicing elit. Aut quod quisquam optio facilis dolore quia quaerat perspiciatis sunt, soluta vero eaque quam illo reiciendis velit dicta recusandae neque? Suscipit repudiandae sapiente error numquam est non, consequatur ducimus nisi. Magnam, ullam beatae! Laudantium quia sunt eos cum. In tempora delectus, odit quis totam non ad quasi laborum impedit harum praesentium consequatur iusto voluptas quaerat quisquam ratione aliquam enim! Impedit, corrupti soluta. (Added: Fri Nov 11 2022 Hits: 40 Rating: 0.00 Votes: 0) Rate It

• About brain fog symptoms,Long covid care center summarizes effective ways to relieve brain fog - Over the past two years, the media, politicians, public health authorities, and others have closely followed the number of lives lost to COVID-19: more than a million have so far been lost. Yet we rarely hear how many Americans have lost their health to COVID-19. According to the survey, nearly one-fifth of adults who have been infected with COVID-19 in the past still have at least Long COVID symptoms — such as brain fog, and fatigue, which is a typical symptom of Long COVID. Previous research on the coronavirus has shown that cured patients may experience neurological symptoms such as memory loss, attention deficit, and slow processing. A large proportion of COVID-19 survivors complain of memory loss more than 100 days after being discharged from the hospital. These symptoms are collectively referred to as "brain fog". A large medical center in Chicago found that more than 40% of COVID-19 patients had neurological manifestations at the beginning, and more than 30% of them were cognitively impaired. People who survive COVID-19 infection may have long-term neurological consequences, and growing evidence suggests that many survivors may experience mild brain damage, leading to general but subtle cognitive, behavioral, and psychological problems. In this regard, the LongCOVIDCareCenter.Org studied the symptoms of long-term COVID-19 and concluded the pathogenesis of long-term new crown brain fog symptoms: 1. Patients infected with the new coronavirus still have many antigenic fragments of the new coronavirus remaining in their bodies. 2. The new coronavirus breaks through the blood-brain barrier and invades the brain 3. The new coronavirus directly invades the brain nerves and damages neuronal pathways. 4. Patients infected with the new coronavirus will have vascular inflammation and micro coagulation, resulting in local hypoxemia. If this happens in the brain, it will cause slight hypoxia in the brain, which will damage the brain nerves. At the same time, the LongCOVIDCareCenter.Org provides some suggestions for patients with brain fog symptoms after the new crown from the perspective of Western medicine and traditional Chinese medicine, as well as daily life and diet: Western medicine treatment plan: First, a comprehensive physical examination of the patient's body requires four further examinations in addition to the routine physical examination. The first is to do two more PCR tests to see if the test is positive. If it is positive, it means that there is still an active new coronavirus in the body. The second item is a neurological examination. Because of the high incidence of neurological symptoms in long-term COVID-19 patients, it is recommended that all chronic COVID-19 patients undergo neurological testing to determine pathophysiology. The third item, in addition to basic blood tests, assessed thyroid hormones, zinc, ferritin, antinuclear antibodies, rheumatoid factor, and blood sedimentation rate in almost all patients. The fourth item is a comprehensive cardiac function test. When persistent tachypnea is found, evaluation for anemia, signs of heart failure, hidden arrhythmias (eg, atrial fibrillation), and enteroinflammatory pneumonitis, as well as for oxygen desaturation with exercise, must be performed. Chinese medicine treatment plan (1) To carry out the diagnosis of traditional Chinese medicine, and to consult the comprehensive physical examination report and four special examination reports of Western medicine. To make the most accurate diagnosis and treatment of the patient's situation. (2) According to the most comprehensive condition information of the patient, the main symptoms, accompanying secondary symptoms, physical condition, and diseased parts of the internal organs are classified and summarized. (3) Based on the above summary, combined with the internal organs and meridians related to symptoms, comprehensively use the theory and practical experience of traditional Chinese medicine, and prescribe traditional Chinese medicine prescriptions to patients. If acupuncture is needed, acupuncture and moxibustion will also be prescribed. Health products to Help Treat Brain Fog (1) Omega 3 (Ω3) fatty acid, containing high amounts of DHA and EPA, is used to improve fatigue function and protect cardiovascular and cerebrovascular. (2) Vitamin C, D, E. It is used to scavenge free radicals, resist oxidation, and reduce chronic inflammation throughout the body. (3) Curcumin, and carotene, are used to scavenge free radicals, and antioxidant, activate NRF2, and reduce chronic inflammation throughout the body. (4) American ginseng, sliced to make tea or reused American ginseng capsules to invigorate Qi. daily diet plan (1) Control the intake of carbohydrates, reduce the amount of staple food of rice and noodles, and control the intake of animal fats. (2) Take a bath before going to bed until you sweat slightly, and lie on the bed to do whole-body muscle tension and relaxation training. To improve sleep. (Added: Fri Nov 11 2022 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• International Congress on Cosmetology and Plastic Surgery - On behalf of our Scientex organizing committee, we cordially invite you to the "International Congress on Cosmetology and Plastic Surgery," which will be held on May 18-19, 2023 in Tokyo, Japan. It mainly focuses on the theme “Scientific Research and Medical Revolutions in Cosmetology & Plastic Surgery”. COSMETOLOGY CONGRESS 2022 will be an outstanding event that will bring together a diverse multinational blend of businesses or sectors, as well as leading universities and academic institutions, making it an ideal forum for sharing knowledge across business and academia and evaluating emerging cosmetology and Plastic Surgery technologies around the world. (Added: Fri Nov 11 2022 Hits: 32 Rating: 0.00 Votes: 0) Rate It

• This Thanks Giving Turn Denials into Reimbursements with Medisys Data Solutions - Delaware, 11-08-2022- Insufficient and inaccurate patient information, duplicate billing, improper and outdated use of codes, etc., continue to put enormous pressure on healthcare organizations’ bottom lines. A situation exacerbated by unresolved claims denials, which represent an average annual loss of $5 million for hospitals and up to 5% of net patient revenue. Hospital denial rates have risen by more than 20% in the last five years, with average claims denial rates reaching 10% or higher. “Nearly 20% of all claims are denied, and up to 60% of returned claims are never resubmitted. The cost of reworking or appealing denials, which averages $25 per claim for practices and $181 per claim for hospitals, adds to the financial hit impacting the reimbursement rates,” as per the Medical Group Management Association (MGMA) “The good news is that denial does not inevitably result in claims being written off. Indeed, up to two-thirds of denied claims are recoverable. A strategic approach to ensure the procedure aligns with payer requirements is required for success—and lower recovery costs. All thanks to the experienced team of Medisys, doubling the reimbursement rates with special thankful offers. Buckle Up Reimbursement with Thanks Giving Offers “To limit the financial impact of denied claims, the best strategy is to avoid them in the first place,” says, Abby, CEO of Medisys Understanding why claims are denied and how to resolve them is most critical to preventing or at least mitigating the damage claims denials can cause to the bottom line. As a token of appreciation for the priceless efforts of the healthcare providers, Medisys has come up with exclusive Thanks Giving offers that will definitely save huge dollars while preventing denials this Thanks Giving Month." These exciting offers will undoubtedly be of tremendous assistance to healthcare companies still struggling to increase their revenue (reimbursement) and to practices and solo practitioners whose billing processes were utterly disrupted by the increased number of claim denials. Additional benefits on this Thanks Giving offer include: 20% off on first three invoices – Huge savings of a flat 20% amount can be used for reinvesting in your healthcare company or practice. Medisys ICD-10 expert coder team exceptionally performs in reviewing the coding charts and showcases the errors for denials as a part of this saving. $4.99/Hour Billing Rate – Medisys has an expert team who work exclusively on the overall billing process and audit the piled-up AR to keep you away from stress occurred due to pending claims money, thereby increasing your revenue in no time. All this can be availed at a nominal rate of $4.99/ hour with a 75,000-billing volume (minimum). Additional Surprise this Thanks Giving: Free Credentialing Services Get all your documents validated with free credentialing services offered by the Medisys team, and make your medical billing process weightless to handle. Credentialing significantly impacts the revenue cycle, as even minor mistakes or interruptions in the process can lead to claim denials, underpayments, and reimbursement delays. Free Credentialing is a value add service in sync with the 20% off offer. Combination of both these deals, will surely save huge dollars for Providers. According to Abby, CEO of Medisys, credentialing provides a plethora of benefits to medical practices and expands the scope of improving their business with more patient inflow. In addition to increasing patient trust in selected healthcare providers, medical credentialing protects healthcare organizations and hospitals from losses. Furthermore, it significantly reduces the risk of medical errors and improves practitioners' business. The Thanks Giving offer appears promising, and the company's primary goal is to ensure that maximum practices take advantage of it. This offer will undoubtedly be a game changer for healthcare providers, significantly increasing their revenue. About Medisys Medisys is a leading provider of medical billing and coding services in the United States, with over a decade of experience dealing with accurate claims submission and denial management, as well as an expert in the revenue management cycle. It is a one-stop solution for all billing needs and defines a new meaning to medical billing and coding in the books of healthcare. Some of the top qualities and areas in which Medisys excels to persuade its clients are as follows: - Highly skilled and extensive expertise in medical billing and coding - Simple and painless on-boarding process for new clients - Excellent management of rejected and pending claims, as well as aged accounts receivables - Instant and real-time response to queries and clarifications - Dedicated, experienced, and certified billing and coding team with high-end supervision of every aspect of your claim This Thanks Giving offer will be a non-denying opportunity for healthcare providers who want to enhance their revenue and streamline their operations with effective medical billing services. This offer will be valid only till the 30th of November 2022 & those who are interested can grab this with a simple registration process. Media Contact Abby, Medisys Data Solutions Inc, 8 The Green STE A, Dover, Delaware - 19901 Tel: +1 888-720-88847 Email – info@medisysdata.com Website – https://www.medisysdata.com/ (Added: Wed Nov 09 2022 Hits: 26 Rating: 0.00 Votes: 0) Rate It

• World Congress on Heart and Cardiovascular Diseases - On behalf of the organizing committee of Cardiology 2023, We are pleased to announce the “World Congress on Heart and Cardiovascular Diseases” which will be held in Tokyo, Japan during May 18-19, 2023. This meeting will explore the latest numerous research and advances in the Cardiology field. With the theme of “Novel Progression Towards the Heart and Cardiovascular Research”, Scientex Conferences is happy to extend an invitation to you for this hybrid event. The Cardiology 2023 Conference is a great opportunity for young people who are working on cardiovascular diseases to come together and share their knowledge. (Added: Wed Nov 09 2022 Hits: 40 Rating: 0.00 Votes: 0) Rate It

• Andalou Naturals Skin Care Products Now Available at National Nutrition - ORILLIA, ON: October 20, 2022 - Andalou Naturals, one of the fastest-growing natural skin care brands in the industry, announced that a larger assortment of its science-backed skin care products is now available at National Nutrition, Canada's largest health food retailer. The addition of more Andalou Naturals products to National Nutrition's retail lineup makes it easier for Canadians to purchase clean products that are free from harmful chemicals and preservatives but still deliver real results. Clean Skincare That Delivers Results Andalou Naturals mission is to offer clean and effective formulations. By combining the benefits of natural ingredients with advanced formulation techniques, Andalou Naturals products deliver active nutrients directly into skin cells to visibly rescue, repair, and protect against damage caused by everyday environmental stressors. Andalou Naturals skincare innovation is PhytoCellTec® Fruit Stem Cell Science, which can be found in their products. Andalou Naturals products are free of parabens, phthalates, synthetic fragrances, and dyes and their products are 98% naturally derived and cruelty-free (they never test on animals). The brand is also committed to sustainable practices and proudly supports local farmers who farm their raw materials responsibly. Andalou Naturals is committed to pushing the boundaries of science while empowering women. They offer a range of skincare products, including serums, cleansers, moisturizers, eye creams, and more that can be used individually or as part of a daily regimen. National Nutrition Adding 160 New Andalou Naturals Products to Their Lineup Founded in 1996, National Nutrition is committed to offering the best in natural health brands and products to its customers. Now NN customers can shop a broad range of over 160 Andalou Naturals products, including skincare, body care and haircare that are formulated with plant-based ingredients and essential oils. Andalou Naturals Citrus Sunflower Body Lotion is a nourishing lotion to soften dry skin. It contains emollient-rich ingredients, such as rosehip and argan oils, shea butter, and cocoa butter and it has been dermatologist-tested. National Nutrition will also now be carrying Andalou Naturals' Get Started Skin Care Essentials kits. These kits take the guesswork out of building a skincare routine that works. With kits available to target breakouts and dull skin, Andalou Naturals has a regimen for everyone! This partnership will also offer a wider assortment of Andalou Naturals' beautiful hair and body products, including Exotic Marula Oil shampoo and conditioners, which feature a patented fruit stem cell complex plus marula oil to deeply moisturize and tame even the most defiant of hair. Andalou Naturals face masks are another quality product that is available to National Nutrition's customers. By incorporating premium ingredients such as goji berries and turmeric, these face masks gently exfoliate the skin to promote cellular turnover without over-drying. "Andalou Naturals is excited about this partnership and we are thrilled to be able to support National Nutrition’s customers in choosing a healthier option for natural body and skin care products," says Elizabeth Fenlon, Key Account Manager at Andalou Naturals. "National Nutrition is the leading natural health products retailer in Canada and we deeply respect their commitment to providing education to their customers, as such, we know their customers will appreciate our science-backed approach to our formulations." National Nutrition's CEO, Darren Firth says: "It used to be that people had to choose between efficacious products and natural products. Not anymore. Andalou Naturals makes products that provide proven results, without the nasty chemicals. The latest addition to the Andalou Naturals range comes in response to great interest from our customers looking for effective skincare products that are clean from harmful chemicals and do not test on animals." Andalou Naturals full range of products can be found on their designated brand page Andalou Naturals at National Nutrition.ca About National Nutrition For over 25 years, National Nutrition dot CA has remained a customer favourite for vitamins and supplements. Their customer-oriented approach and high-quality supplement range from leading brands have led them to be Canada’s trusted name in all things natural health. They even take it one step further and provide educational content for their customers through videos on their Youtube Channel and Supplement articles on their website. (Added: Wed Nov 09 2022 Hits: 54 Rating: 0.00 Votes: 0) Rate It

• 10 Benefits of Tulsi (Holy Basil) leaves - Boost immunity, Heals the infection - Tulsi plant is considered very sacred in a religious form, it is considered auspicious to plant them in the house or courtyard. It is believed that planting tulsi in the house removes all the negativity as well as brings happiness and prosperity to the family, But do you know that as much importance as Tulsi plant in Religious, it is same importance in Ayurveda? In Ayurveda, Tulsi is considered a medicinal plant, which protects humans from many diseases. Tulsi is very beneficial for our health, and we will know some of its benefits from this blog. (Added: Mon Nov 07 2022 Hits: 47 Rating: 0.00 Votes: 0) Rate It

• caretaker services vizag - Our Nursing Services offer assistance in Senior Care (Eldercare), and the specific care and management of health conditions such as Stroke Rehabilitation and Recovery, Cancer, Parkinson’s Disease, and Diabetes. Our Physiotherapy services focus on pain management, whereas Caregiver (Aide) services provide bedside attendants and general caretakers that will offer professional help for the care and management of people recovering from surgery/injuries and for those suffering from long-term illnesses. (Added: Mon Nov 07 2022 Hits: 38 Rating: 0.00 Votes: 0) Rate It

• Pediatric Cardiology-2023 conference - We are pleased to welcome you to participate in the "5th Annual Congress on Pediatric Cardiology” which is going to be held during March 23-24, 2023 at Vancouver, Canada. • All accepted abstracts will be published in the respective Journals. • Each abstract will receive a DOI provided by Cross Ref. • Exceptional privileges on group registrations. • Opening to organize Workshop/Symposia. • Outstanding Young Researcher Award and Best Poster Award Speaker and abstract pages created in Google on your name would get worldwide. (Added: Mon Nov 07 2022 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• Top reasons to visit chiropractor Pontyclun - United Kingdom 07.11.2022 The advantages of Pontyclun chiropractor changes are that they can keep the well-being and improvement of your spine dynamic as well as youthful. When the fragile spine cannot curve and wind with the most remarkable abilities, you'll observe that your scope of movement is diminished at any point. That torment emanates from odd places and can adversely influence your satisfaction. 1. Reduced irritation: Aggravation is attached to persistent agony. Chiropractor Pontyclun care diminishes aggravation to work to your satisfaction. 2. Enhanced adaptability: Tight muscles confine your development. Regular chiropractic care relaxes them so you can easily play out your everyday exercises. 3. Boosted athletic execution: With less torment, diminished irritation, and further developed adaptability, your athletic exhibition gets a lift. You are less inclined to experience a game injury when you get preventive chiropractic changes. 4. Increased bloodstream to the mind: An appropriately adjusted spine enhances course throughout the body, including the cerebrum. Chiropractor Pontyclun can give genuinely necessary help to individuals with neurological circumstances like epilepsy and various sclerosis. 5. Treatment for dizziness: Weakening tipsiness is often the consequence of a horrendous head or neck injury bringing about a crooked spine. If you're encountering dizziness, a chiropractor specialist might be able to help. 6. Lower circulatory strain: Pontyclun chiropractor focusing on the cervical spine or neck can be similarly as successful at bringing down pulse as taking pulse drug. 7. Boosted resistance: Your insusceptible framework is liable for fending diseases and contaminations. Indeed, even a somewhat skewed spine could hinder invulnerable capability, an issue effectively helped by chiropractic change. 8. Reduced sensitivity side effects: Sensitivities are the aftereffect of a misrepresented safe reaction. The fundamental reason might be a skewed spine obstructing signals from the cerebrum. Provided that this is true, visiting a Chiropractor specialist could assist with facilitating your side effects. 9. Improved assimilation: Issues with the sensory system in your thoracic spine, or center back, can prompt heartburn, gas, and acid reflux. Regular chiropractic care can realign the vertebrae around, which might ease stomach issues. 10. Maximized lung capability: Ongoing back agony might decrease lung limit. Treat your sickness with spinal changes; before long, you'll breathe profoundly without torment. For more details visit at: https://www.sands-clinic.co.uk/chiropractic (Added: Mon Nov 07 2022 Hits: 71 Rating: 0.00 Votes: 0) Rate It

• Craniotomy Care, Post Craniotomy Care, Craniotomy Post OP Care - The Cure Rehab rehabilitation centre follows a conventional protocol that includes a baseline functional evaluation soon after admission, followed by a follow-up evaluation at least one month later. https://curerehab.in/Craniotomy-Care (Added: Mon Nov 07 2022 Hits: 33 Rating: 0.00 Votes: 0) Rate It

• Amid California Housing Crisis, HPP Cares Offers $40,000 Grants for Residential Construction - FOR IMMEDIATE RELEASE Amid California Housing Crisis, HPP Cares Offers $40,000 Grants for Residential Construction HPP Cares has already given away more than $5 million in ADU grants LONG BEACH, CALIFORNIA, OCTOBER 28, 2022 - As California’s housing crisis continues to grow, HPP Cares has announced the opening of a new portal where $40,000 grants for the construction of ADUs (accessory dwelling units) can be applied for. This portal will be open until November 18, 2022. Current statistics paint a grim picture for California’s housing situation. The California housing shortage is estimated at nearly one million units. Renters pay 44% above the national median, while the median household income is only 22% higher than the national average. One of the solutions to this housing crisis rests in ADUs, but there is one major obstacle: funding. HPP Cares was founded by Katherine Peoples with a mission of providing consumer credit, debt, and housing counseling. Peoples has used her experience in business law, communication, advocacy, and real estate, to successfully assist consumers across the state while building a team of like-minded professionals at HPP Cares. Today, the HUD-approved non-profit offers a wealth of consumer assistance including budget counseling, housing counseling, and debt management strategies. Now, the organization has announced a partnership with CalHFA in which grants are offered to help construct ADUs. The grants are $40,000 and give recipients the ability to either use all the cash for construction or couple the grant money with other funding, such as loans, to build an ADU. For example, the county limits for CalHFA mortgages are at $235,000 in Orange County, $173,000 in Riverside, and $282,000 in Alameda, demonstrating a need for funding to fill the gap between actual costs and mortgage amounts available. This exclusive opportunity is opening the door for new housing units in California by reimbursing pre-development costs commonly associated with the construction of ADUs. This comes at a time when the state’s housing sector is suffering greatly, as is noted by low RHNA (Regional Housing Needs Allocation) numbers in counties across California. The team at HPP Cares is thrilled to be part of a viable solution to the housing crisis and has received support from elected officials from around the state, including Senator Skinner. The ADU grant program from HPP Cares has already proven beneficial and has given away $5 million in grants. The portal has just officially opened. Applicants can now visit the HPP Cares and complete their applications for the $40,000 grant funding. “The HPP Cares team is beyond thrilled to bring this amazing opportunity to people across California. The portal is now open, and we encourage anyone interested in ADU construction to go ahead and apply,” said Peoples. More information can be found at https://www.hppcares.org/. ABOUT HPP CARES HPP Cares is a California non-profit certified HUD approved consumer credit, debt, and housing counseling agency that provides personal assistance via budget counseling, housing counseling, and debt management strategies. CONTACT Shawna Charles Charles Communication Group Phone: 310.689.4310 E-mail: publicity@charlescg.com Facebook: @HPPCARESCDE Instagram: @hppcares LinkedIn: @hpp-cares Website: https://www.hppcares.org/ ### (Added: Sat Nov 05 2022 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Dementia focused Kickstarter - For immediate release The Timeless Trainset: A gift for those with Dementia, helps connecting with people and encourages self expression. Launching on Kickstarter mid-November. Including an option to donate a train set to a UK care home. Kent, UK, 3 November 2022 – Timeless Presents Ltd (website live in mid-November) announces the launch of a Kickstarter Campaign for The Timeless Trainset. Their concept is aimed at helping to fill the gap in current thinking about engagement with those in the mid to late stages of Dementia. As sufferers journey into the later stages of the condition their ability to initiate thoughts around activities they might like to participate in significantly diminishes. This can give the impression that their sense of self has also gone, but this isn't the case. Unfortunately for millions of Dementia sufferers around the world this can lead to a life of boredom and frustration. Sharon and Chris Daltrey, owners of Timeless Presents, saw Sharon's father, Brian, struggling with these issues as his Alzheimers slowly progressed, so they tried to think of fresh ways to engage with him. "Visits to see Dad at his care home were gradually becoming more difficult" explains Sharon, "Dad's ability to form new memories had gone and asking him something as simple as what he had for lunch could cause him to become anxious." "We had been told that generally memories were lost in reverse order, with the earliest being the last to go" says Chris "an example of this was that Brian could still remember all the words to some nursery rhymes right up to the end." "This led us to think that Dad might often be existing in a much younger state to his chronological age. The first thing we bought him was a wooden train set, and although some thought it was a childish thing to do, he absolutely loved it, and that was the most important thing to us. And while we were playing with it together, because he needed help, we found it was a lovely way to connect with him." said Sharon. They also observed other benefits in Brian, that he recognised and was interested in the set, and having an idea of what he could do with it seemed to boost his agency and self confidence. Sharon says "now that Dad has gone we are launching Timeless Presents Ltd to help others experience what we, and my Dad did." Chris says "The gifting market for mid to late stage dementia is under served and knowing what to get your loved one can be tricky. We're hoping our innovative gift ideas will go some way towards helping this situation". Working with Bigjigs Toys, who co-incidently made Brian's original set, Sharon and Chris have developed a wooden train set to with a more adult style. Included in the set is a world famous steam locomotive, exclusive, era appropriate carriages contained within a cardboard box designed to resemble a vintage suitcase, complete with labels, that can be used for storage. The inner packaging has been designed to resemble the packaging of train sets from the mid-20th century. The set will also come with a useful hints and tips leaflet to help customers on their way to enjoying more moments together. A video for this product can be seen at https://youtu.be/mEPbkPNOp3U Photos are available on request Mobile number 07936408941 email connect@timelesspresents.com (Added: Fri Nov 04 2022 Hits: 31 Rating: 0.00 Votes: 0) Rate It

• Biologics Outsourcing Gobal Market To - 2030 - Biologics are the therapeutic entities composed of sugars, proteins, or nucleic acids and made from natural sources such as human, animal or microorganisms. Biologics also include live attenuated microorganisms (vaccines), allergenic extracts (allergy shots), human cells and tissues (for transplantation), cell and gene therapeutics. Similar to the conventional therapeutics, these drugs help in treating several diseases but are highly specific and more efficient in their disease healing mechanisms. The biologic entities like monoclonal antibodies and recombinant proteins target specific areas during their molecular mechanism of disease curing action. The biologics outsourcing global market is expected to grow at a double digit CAGR from 2022 to 2030 to reach $106.7 billion by 2030. Major drivers for the biologics outsourcing market include increasing trend of outsourcing among the biopharma companies for gaining an economical access to advanced biologics development and manufacturing capacities and capabilities, advanced bioprocessing capabilities of bioservice providers, increasing approvals and adoption of biologics, increasing R&D spend of biopharma companies and escalating approvals and uptake of biosimilars. Factors like emergence of next generation biotherapeutics, development of personalized and orphan indication therapies and the persistently escalating prevalence of chronic, communicable and autoimmune diseases are expected to boost the market growth. However, increasing focus on in-house biologics manufacturing, huge capital investments for capacity and capability development and compliance with stringent regulatory guidelines are restraining the market. The biologics outsourcing global market has been segmented based on the developmental phase, product, end users and geography. Based on the phase, biologics outsourcing global market segmented into discovery, pre-clinical, clinical and commercial phases of biologics development. Among these, Commercial Phase outsourcing commanded the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Clinical outsourcing segment is expected grow early teen CAGR from 2022 to 2030. Based on the product type, biologics outsourcing global market is segmented into Antibody, Proteins, Vaccines, Gene therapy, cell therapy and others. Among these, the antibody outsourcing segment accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 20230. Gene therapeutics segment is expected grow at a high double digit CAGR from 2022 to 2030. Based on end-users, biologics outsourcing global market is segmented into Therapeutics, Diagnostics and Research. Among these, Therapeutics accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on geography, biologics outsourcing global market is segmented into North America, Europe, Asia-Pacific and RoW. North America dominated the biologics outsourcing market with the highest revenue in 2022 and is expected to grow at high single digit CAGR 2022 to 2030. Whereas, Asia Pacific region is expected to be grow at an early teen CAGR from 2022 to 2030. The report specifically emphasizes on the rapidly evolving and high growth potential biologics contract manufacturing services market and cell line development services market. The biologics contract manufacturing global market is expected to grow at double digit CAGR from 2022 to 2030. The contract biomanufacturing global market is driven by the increasing trend of outsourcing among the biopharmaceutical companies, availability of advanced bioprocessing capabilities among the contract bioservice providers, expansion of manufacturing facilities, and the escalating approval and adoption of biologics and the cost effective biosimilars among the value centric global patient pool leading to huge volume demand for biologics. Emergence of advanced biotherapeutics, increasing R&D investments by the biopharma companies, development of precision and orphan indication therapies and the persistently increasing prevalence of chronic, communicable and autoimmune diseases are also boosting contract biomanufacturing market growth. The biologics contract biomanufacturing services global market is classified based on product, developmental phase, process, end users and geography. Based on the product, the biologics CMO global market divided into Drug substance manufacturing and Drug product manufacturing. Among these, drug substance manufacturing accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. The Drug Product manufacturing is expected to grow at an early teen CAGR from 2022 to 2030. Based on the developmental phase, the contract Biomanufacturing global market has been segmented as clinical phase contract biomanufacturing and commercial phase contract biomanufacturing. Among these phases, the commercial phase contract biomanufacturing accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Clinical segment is expected to grow at an early teen CAGR from 2022 to 2030. Based on the process of contract biomanufacturing, the global market has been grouped into mammalian contract biomanufacturing, microbial contract biomanufacturing and other contract biomanufacturing processes (plant or insect cell based). Among these, mammalian cell culture CMO market is accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. The contract biomanufacturing services global market, based on end-users has been segmented into contract biomanufacturing for diagnostics, research reagents and therapeutics. Among these, contract biomanufacturing of therapeutics accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. Research segment is expected to grow at an early teen CAGR from 2022 to 2030. The vectors are basic important components in the development of biological modalities such as gene therapy, cell therapy, vaccines and also in the development of recombinant cell lines CHO and others for the production of biologics such as monoclonal antibodies, recombinant proteins and others. The Viral Vector & Plasmid DNA Contract Manufacturing global market is estimated to be $XX million in 2022 and is expected to grow at early teen CAGR from 2022 to 2030. Based on vector type, Viral Vector & Plasmid DNA Contract Manufacturing global market is divided into viral vector and plasmid DNA manufacturing. Among these, Plasmid DNA Contract Manufacturing segment is accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2030. Viral vector Contract Manufacturing is expected to grow at a high teen CAGR from 2022 to 2030. Based on modalities, Viral Vector and Plasmid DNA contract manufacturing global market is segmented into Vaccines, Cell & Gene Therapies and Others. Among these, Vaccines segment is accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2030. Cell & Gene Therapies is expected to grow at a high double digit CAGR from 2022 to 2030 due to growing cell and gene therapies pipelines and expanding vector manufacturing capabilities are driving the cell and gene therapies application market. Based on the facility type, it can be categorized into Stainless steel and Single-use. Stainless steel CMO global manufacturing capacity is estimated to be XX million L in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2030. Single-Use CMO global manufacturing capacity is expected to grow at a high double digit CAGR from 2022 to 2030. The contract biomanufacturing services global market based on geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (ROW). North America contributed highest revenue in 2022 and is growing at a high single digit CAGR from 2022 to 2030. Asia Pacific region is expected to grow at an early teen CAGR from 2022 to 2030. The cell line development service market is expected to grow at a double digit CAGR from 2022 to 2030 to reach $2,093.2 million by 2030. Increasing demand for monoclonal antibodies, recombinant proteins and vaccines, growing incidence rate of oncology, autoimmune disorders, infectious diseases & genetic disorders and growth in research activities related to the diseases and also recombinant cell lines for the production recombinant biopharmaceutical proteins are driving the market. Technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market. However, complexities in the development of stable cell lines and high risk of contamination due to complex purification methods are restraining the market. Furthermore, stringent and complex regulations and the high cost and technical requirement to adhere to accreditations such as GMP are posing threat to the industry. Cell line development service global market is classified based on the expression system, cell line type, application and geography. Based on expression system, cell line development service global market is segmented into microbial, mammalian and others. Among these, mammalian expression system is accounted for the highest revenue of in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on the cell line type, global cell line development service market is segmented into CHO, Mouse Myeloma (NS0; Sp2/0), Human Embryonic Kidney (HEK), Baby Hamster Kidney (BHK), Hybridoma, Human Embryonic Retina (PER.C6) and others. Among these, CHO cell line accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. Based on application, cell line development service global market is segmented into research, bio production and diagnostics. Among these, bioproduction segment accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on the geography, cell line development service global market is segmented into North America, Europe, Asia-Pacific and Rest of the world. North America commanded the highest revenue in 2022. The market is expected to grow at a high single digit CAGR from 2022 to 2030. Asia Pacific is expected to grow at an early teen CAGR from 2022 to 2030. The Biologics R&D Spending Global Market is estimated to be $XX billion in 2022, of which CRO market penetration is ~13.6% ($XX billion) and Biologics Manufacturing Global Market is estimated to be $XX billion in 2022, of which CMO market penetration is ~XX% ($XX billion). The contract biomanufacturing services global market is fragmented with the top six players occupying only a meager or modest share of XX% of the market and the remaining bulk share of 74.1% the market being occupied by other players. The cell line development services global market is consolidated with the top six players occupying major share of XX% of the market and the other players occupying only a modest share of XX% the market. The biologics outsourcing global market is fragmented with the top six players occupying modest share of XX% of the market and the remaining other players occupying the major part of the market. The top players in biologics outsourcing global market are Lonza (Switzerland), Catalent (U.S.), SamSung Biologics (South Korea), WuXi Biologics (China), Thermo Fisher (Patheon N.V.+Brammer Bio) (U.S.), FUJIFILM Holdings Corporation (FujiFilm Diosynth) (Japan), Merck KGaA (Germany), Boehringer Ingelheim (Germany), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories (U.S.), JSR corporation (U.S.), WuXi Apptech (China), Genscript Biotech Corporation (China), Emergent Biosciences (U.S.), Asahi Glass Company (AGC Biologics) (Japan) and others. (Added: Wed Nov 02 2022 Hits: 34 Rating: 0.00 Votes: 0) Rate It

• Biologics Outsourcing Gobal Market To - 2030 - Biologics are the therapeutic entities composed of sugars, proteins, or nucleic acids and made from natural sources such as human, animal or microorganisms. Biologics also include live attenuated microorganisms (vaccines), allergenic extracts (allergy shots), human cells and tissues (for transplantation), cell and gene therapeutics. Similar to the conventional therapeutics, these drugs help in treating several diseases but are highly specific and more efficient in their disease healing mechanisms. The biologic entities like monoclonal antibodies and recombinant proteins target specific areas during their molecular mechanism of disease curing action. The biologics outsourcing global market is expected to grow at a double digit CAGR from 2022 to 2030 to reach $106.7 billion by 2030. Major drivers for the biologics outsourcing market include increasing trend of outsourcing among the biopharma companies for gaining an economical access to advanced biologics development and manufacturing capacities and capabilities, advanced bioprocessing capabilities of bioservice providers, increasing approvals and adoption of biologics, increasing R&D spend of biopharma companies and escalating approvals and uptake of biosimilars. Factors like emergence of next generation biotherapeutics, development of personalized and orphan indication therapies and the persistently escalating prevalence of chronic, communicable and autoimmune diseases are expected to boost the market growth. However, increasing focus on in-house biologics manufacturing, huge capital investments for capacity and capability development and compliance with stringent regulatory guidelines are restraining the market. The biologics outsourcing global market has been segmented based on the developmental phase, product, end users and geography. Based on the phase, biologics outsourcing global market segmented into discovery, pre-clinical, clinical and commercial phases of biologics development. Among these, Commercial Phase outsourcing commanded the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Clinical outsourcing segment is expected grow early teen CAGR from 2022 to 2030. Based on the product type, biologics outsourcing global market is segmented into Antibody, Proteins, Vaccines, Gene therapy, cell therapy and others. Among these, the antibody outsourcing segment accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 20230. Gene therapeutics segment is expected grow at a high double digit CAGR from 2022 to 2030. Based on end-users, biologics outsourcing global market is segmented into Therapeutics, Diagnostics and Research. Among these, Therapeutics accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on geography, biologics outsourcing global market is segmented into North America, Europe, Asia-Pacific and RoW. North America dominated the biologics outsourcing market with the highest revenue in 2022 and is expected to grow at high single digit CAGR 2022 to 2030. Whereas, Asia Pacific region is expected to be grow at an early teen CAGR from 2022 to 2030. The report specifically emphasizes on the rapidly evolving and high growth potential biologics contract manufacturing services market and cell line development services market. The biologics contract manufacturing global market is expected to grow at double digit CAGR from 2022 to 2030. The contract biomanufacturing global market is driven by the increasing trend of outsourcing among the biopharmaceutical companies, availability of advanced bioprocessing capabilities among the contract bioservice providers, expansion of manufacturing facilities, and the escalating approval and adoption of biologics and the cost effective biosimilars among the value centric global patient pool leading to huge volume demand for biologics. Emergence of advanced biotherapeutics, increasing R&D investments by the biopharma companies, development of precision and orphan indication therapies and the persistently increasing prevalence of chronic, communicable and autoimmune diseases are also boosting contract biomanufacturing market growth. The biologics contract biomanufacturing services global market is classified based on product, developmental phase, process, end users and geography. Based on the product, the biologics CMO global market divided into Drug substance manufacturing and Drug product manufacturing. Among these, drug substance manufacturing accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. The Drug Product manufacturing is expected to grow at an early teen CAGR from 2022 to 2030. Based on the developmental phase, the contract Biomanufacturing global market has been segmented as clinical phase contract biomanufacturing and commercial phase contract biomanufacturing. Among these phases, the commercial phase contract biomanufacturing accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Clinical segment is expected to grow at an early teen CAGR from 2022 to 2030. Based on the process of contract biomanufacturing, the global market has been grouped into mammalian contract biomanufacturing, microbial contract biomanufacturing and other contract biomanufacturing processes (plant or insect cell based). Among these, mammalian cell culture CMO market is accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. The contract biomanufacturing services global market, based on end-users has been segmented into contract biomanufacturing for diagnostics, research reagents and therapeutics. Among these, contract biomanufacturing of therapeutics accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. Research segment is expected to grow at an early teen CAGR from 2022 to 2030. The vectors are basic important components in the development of biological modalities such as gene therapy, cell therapy, vaccines and also in the development of recombinant cell lines CHO and others for the production of biologics such as monoclonal antibodies, recombinant proteins and others. The Viral Vector & Plasmid DNA Contract Manufacturing global market is estimated to be $XX million in 2022 and is expected to grow at early teen CAGR from 2022 to 2030. Based on vector type, Viral Vector & Plasmid DNA Contract Manufacturing global market is divided into viral vector and plasmid DNA manufacturing. Among these, Plasmid DNA Contract Manufacturing segment is accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2030. Viral vector Contract Manufacturing is expected to grow at a high teen CAGR from 2022 to 2030. Based on modalities, Viral Vector and Plasmid DNA contract manufacturing global market is segmented into Vaccines, Cell & Gene Therapies and Others. Among these, Vaccines segment is accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2030. Cell & Gene Therapies is expected to grow at a high double digit CAGR from 2022 to 2030 due to growing cell and gene therapies pipelines and expanding vector manufacturing capabilities are driving the cell and gene therapies application market. Based on the facility type, it can be categorized into Stainless steel and Single-use. Stainless steel CMO global manufacturing capacity is estimated to be XX million L in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2030. Single-Use CMO global manufacturing capacity is expected to grow at a high double digit CAGR from 2022 to 2030. The contract biomanufacturing services global market based on geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (ROW). North America contributed highest revenue in 2022 and is growing at a high single digit CAGR from 2022 to 2030. Asia Pacific region is expected to grow at an early teen CAGR from 2022 to 2030. The cell line development service market is expected to grow at a double digit CAGR from 2022 to 2030 to reach $2,093.2 million by 2030. Increasing demand for monoclonal antibodies, recombinant proteins and vaccines, growing incidence rate of oncology, autoimmune disorders, infectious diseases & genetic disorders and growth in research activities related to the diseases and also recombinant cell lines for the production recombinant biopharmaceutical proteins are driving the market. Technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market. However, complexities in the development of stable cell lines and high risk of contamination due to complex purification methods are restraining the market. Furthermore, stringent and complex regulations and the high cost and technical requirement to adhere to accreditations such as GMP are posing threat to the industry. Cell line development service global market is classified based on the expression system, cell line type, application and geography. Based on expression system, cell line development service global market is segmented into microbial, mammalian and others. Among these, mammalian expression system is accounted for the highest revenue of in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on the cell line type, global cell line development service market is segmented into CHO, Mouse Myeloma (NS0; Sp2/0), Human Embryonic Kidney (HEK), Baby Hamster Kidney (BHK), Hybridoma, Human Embryonic Retina (PER.C6) and others. Among these, CHO cell line accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. Based on application, cell line development service global market is segmented into research, bio production and diagnostics. Among these, bioproduction segment accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on the geography, cell line development service global market is segmented into North America, Europe, Asia-Pacific and Rest of the world. North America commanded the highest revenue in 2022. The market is expected to grow at a high single digit CAGR from 2022 to 2030. Asia Pacific is expected to grow at an early teen CAGR from 2022 to 2030. The Biologics R&D Spending Global Market is estimated to be $XX billion in 2022, of which CRO market penetration is ~13.6% ($XX billion) and Biologics Manufacturing Global Market is estimated to be $XX billion in 2022, of which CMO market penetration is ~XX% ($XX billion). The contract biomanufacturing services global market is fragmented with the top six players occupying only a meager or modest share of XX% of the market and the remaining bulk share of 74.1% the market being occupied by other players. The cell line development services global market is consolidated with the top six players occupying major share of XX% of the market and the other players occupying only a modest share of XX% the market. The biologics outsourcing global market is fragmented with the top six players occupying modest share of XX% of the market and the remaining other players occupying the major part of the market. The top players in biologics outsourcing global market are Lonza (Switzerland), Catalent (U.S.), SamSung Biologics (South Korea), WuXi Biologics (China), Thermo Fisher (Patheon N.V.+Brammer Bio) (U.S.), FUJIFILM Holdings Corporation (FujiFilm Diosynth) (Japan), Merck KGaA (Germany), Boehringer Ingelheim (Germany), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories (U.S.), JSR corporation (U.S.), WuXi Apptech (China), Genscript Biotech Corporation (China), Emergent Biosciences (U.S.), Asahi Glass Company (AGC Biologics) (Japan) and others. (Added: Wed Nov 02 2022 Hits: 23 Rating: 0.00 Votes: 0) Rate It

• Biologics Outsourcing Global Market Forecast To - 2030 - Biologics are the therapeutic entities composed of sugars, proteins, or nucleic acids and made from natural sources such as human, animal or microorganisms. Biologics also include live attenuated microorganisms (vaccines), allergenic extracts (allergy shots), human cells and tissues (for transplantation), cell and gene therapeutics. Similar to the conventional therapeutics, these drugs help in treating several diseases but are highly specific and more efficient in their disease healing mechanisms. The biologic entities like monoclonal antibodies and recombinant proteins target specific areas during their molecular mechanism of disease curing action. The biologics outsourcing global market is expected to grow at a double digit CAGR from 2022 to 2030 to reach $106.7 billion by 2030. Major drivers for the biologics outsourcing market include increasing trend of outsourcing among the biopharma companies for gaining an economical access to advanced biologics development and manufacturing capacities and capabilities, advanced bioprocessing capabilities of bioservice providers, increasing approvals and adoption of biologics, increasing R&D spend of biopharma companies and escalating approvals and uptake of biosimilars. Factors like emergence of next generation biotherapeutics, development of personalized and orphan indication therapies and the persistently escalating prevalence of chronic, communicable and autoimmune diseases are expected to boost the market growth. However, increasing focus on in-house biologics manufacturing, huge capital investments for capacity and capability development and compliance with stringent regulatory guidelines are restraining the market. The biologics outsourcing global market has been segmented based on the developmental phase, product, end users and geography. Based on the phase, biologics outsourcing global market segmented into discovery, pre-clinical, clinical and commercial phases of biologics development. Among these, Commercial Phase outsourcing commanded the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Clinical outsourcing segment is expected grow early teen CAGR from 2022 to 2030. Based on the product type, biologics outsourcing global market is segmented into Antibody, Proteins, Vaccines, Gene therapy, cell therapy and others. Among these, the antibody outsourcing segment accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 20230. Gene therapeutics segment is expected grow at a high double digit CAGR from 2022 to 2030. Based on end-users, biologics outsourcing global market is segmented into Therapeutics, Diagnostics and Research. Among these, Therapeutics accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on geography, biologics outsourcing global market is segmented into North America, Europe, Asia-Pacific and RoW. North America dominated the biologics outsourcing market with the highest revenue in 2022 and is expected to grow at high single digit CAGR 2022 to 2030. Whereas, Asia Pacific region is expected to be grow at an early teen CAGR from 2022 to 2030. The report specifically emphasizes on the rapidly evolving and high growth potential biologics contract manufacturing services market and cell line development services market. The biologics contract manufacturing global market is expected to grow at double digit CAGR from 2022 to 2030. The contract biomanufacturing global market is driven by the increasing trend of outsourcing among the biopharmaceutical companies, availability of advanced bioprocessing capabilities among the contract bioservice providers, expansion of manufacturing facilities, and the escalating approval and adoption of biologics and the cost effective biosimilars among the value centric global patient pool leading to huge volume demand for biologics. Emergence of advanced biotherapeutics, increasing R&D investments by the biopharma companies, development of precision and orphan indication therapies and the persistently increasing prevalence of chronic, communicable and autoimmune diseases are also boosting contract biomanufacturing market growth. The biologics contract biomanufacturing services global market is classified based on product, developmental phase, process, end users and geography. Based on the product, the biologics CMO global market divided into Drug substance manufacturing and Drug product manufacturing. Among these, drug substance manufacturing accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. The Drug Product manufacturing is expected to grow at an early teen CAGR from 2022 to 2030. Based on the developmental phase, the contract Biomanufacturing global market has been segmented as clinical phase contract biomanufacturing and commercial phase contract biomanufacturing. Among these phases, the commercial phase contract biomanufacturing accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Clinical segment is expected to grow at an early teen CAGR from 2022 to 2030. Based on the process of contract biomanufacturing, the global market has been grouped into mammalian contract biomanufacturing, microbial contract biomanufacturing and other contract biomanufacturing processes (plant or insect cell based). Among these, mammalian cell culture CMO market is accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. The contract biomanufacturing services global market, based on end-users has been segmented into contract biomanufacturing for diagnostics, research reagents and therapeutics. Among these, contract biomanufacturing of therapeutics accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. Research segment is expected to grow at an early teen CAGR from 2022 to 2030. The vectors are basic important components in the development of biological modalities such as gene therapy, cell therapy, vaccines and also in the development of recombinant cell lines CHO and others for the production of biologics such as monoclonal antibodies, recombinant proteins and others. The Viral Vector & Plasmid DNA Contract Manufacturing global market is estimated to be $XX million in 2022 and is expected to grow at early teen CAGR from 2022 to 2030. Based on vector type, Viral Vector & Plasmid DNA Contract Manufacturing global market is divided into viral vector and plasmid DNA manufacturing. Among these, Plasmid DNA Contract Manufacturing segment is accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2030. Viral vector Contract Manufacturing is expected to grow at a high teen CAGR from 2022 to 2030. Based on modalities, Viral Vector and Plasmid DNA contract manufacturing global market is segmented into Vaccines, Cell & Gene Therapies and Others. Among these, Vaccines segment is accounted for the highest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2030. Cell & Gene Therapies is expected to grow at a high double digit CAGR from 2022 to 2030 due to growing cell and gene therapies pipelines and expanding vector manufacturing capabilities are driving the cell and gene therapies application market. Based on the facility type, it can be categorized into Stainless steel and Single-use. Stainless steel CMO global manufacturing capacity is estimated to be XX million L in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2030. Single-Use CMO global manufacturing capacity is expected to grow at a high double digit CAGR from 2022 to 2030. The contract biomanufacturing services global market based on geography is segmented into North America, Europe, Asia-Pacific and the Rest of the world (ROW). North America contributed highest revenue in 2022 and is growing at a high single digit CAGR from 2022 to 2030. Asia Pacific region is expected to grow at an early teen CAGR from 2022 to 2030. The cell line development service market is expected to grow at a double digit CAGR from 2022 to 2030 to reach $2,093.2 million by 2030. Increasing demand for monoclonal antibodies, recombinant proteins and vaccines, growing incidence rate of oncology, autoimmune disorders, infectious diseases & genetic disorders and growth in research activities related to the diseases and also recombinant cell lines for the production recombinant biopharmaceutical proteins are driving the market. Technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market. However, complexities in the development of stable cell lines and high risk of contamination due to complex purification methods are restraining the market. Furthermore, stringent and complex regulations and the high cost and technical requirement to adhere to accreditations such as GMP are posing threat to the industry. Cell line development service global market is classified based on the expression system, cell line type, application and geography. Based on expression system, cell line development service global market is segmented into microbial, mammalian and others. Among these, mammalian expression system is accounted for the highest revenue of in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on the cell line type, global cell line development service market is segmented into CHO, Mouse Myeloma (NS0; Sp2/0), Human Embryonic Kidney (HEK), Baby Hamster Kidney (BHK), Hybridoma, Human Embryonic Retina (PER.C6) and others. Among these, CHO cell line accounted for the highest revenue in 2022 and is expected to grow at an early teen CAGR from 2022 to 2030. Based on application, cell line development service global market is segmented into research, bio production and diagnostics. Among these, bioproduction segment accounted for the highest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2030. Based on the geography, cell line development service global market is segmented into North America, Europe, Asia-Pacific and Rest of the world. North America commanded the highest revenue in 2022. The market is expected to grow at a high single digit CAGR from 2022 to 2030. Asia Pacific is expected to grow at an early teen CAGR from 2022 to 2030. The Biologics R&D Spending Global Market is estimated to be $XX billion in 2022, of which CRO market penetration is ~13.6% ($XX billion) and Biologics Manufacturing Global Market is estimated to be $XX billion in 2022, of which CMO market penetration is ~XX% ($XX billion). The contract biomanufacturing services global market is fragmented with the top six players occupying only a meager or modest share of XX% of the market and the remaining bulk share of 74.1% the market being occupied by other players. The cell line development services global market is consolidated with the top six players occupying major share of XX% of the market and the other players occupying only a modest share of XX% the market. The biologics outsourcing global market is fragmented with the top six players occupying modest share of XX% of the market and the remaining other players occupying the major part of the market. The top players in biologics outsourcing global market are Lonza (Switzerland), Catalent (U.S.), SamSung Biologics (South Korea), WuXi Biologics (China), Thermo Fisher (Patheon N.V.+Brammer Bio) (U.S.), FUJIFILM Holdings Corporation (FujiFilm Diosynth) (Japan), Merck KGaA (Germany), Boehringer Ingelheim (Germany), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories (U.S.), JSR corporation (U.S.), WuXi Apptech (China), Genscript Biotech Corporation (China), Emergent Biosciences (U.S.), Asahi Glass Company (AGC Biologics) (Japan) and others. (Added: Wed Nov 02 2022 Hits: 30 Rating: 0.00 Votes: 0) Rate It

• Plutus Health is Exhibiting at WASCA Annual Educational Conference 2022 - Plutus Health is exhibiting at WASCA Annual Educational Conference 2022, organized by Washington Ambulatory Surgery Center Association in Tulalip, WA 98271. WASCA 2022 is one of its kind annual educational conference held on November 3 & 4, 2022. In this education conference & trade show, ASC billing services gather to learn about ways to grow their business and the latest regulatory laws. "Exhibiting at WASCA 2022 is an honor for us," says Thomas John, CEO of Plutus Health Inc. "Regulatory laws keep updating for the ASC. To keep running profitably, ASCs need to comply with these updates." ASC billing services need more billers and coders who are certified and experienced in creating and submitting ASC claims to achieve full reimbursement. Denial rates, coding quality, clean claim percentage, and AR days are the key factors determining an ASC billing service's successful running and profitability. Managing these factors is challenging as ASC coding has multiple codes and modifiers, which keep updating regularly. WASCA 2022 allows ASC owners, staff, and operators to learn billing, coding, and complete revenue cycle management. ASCs can connect with fellow healthcare service providers, professionals who know the inside out of ASC regulation laws, and RCM experts to learn new ways to grow their business. "Providing knowledge and end-to-end RCM billing services to ASCs has been our mission since we started working for the healthcare industry. Plutus Health's experienced ASC billing and coding professionals are our biggest strength in providing exceptional RCM services to grow their business." Added Thomas. ASCs partnered with Plutus Health have shown remarkable results and set a benchmark of growth percentage in terms of submitting clean claims and generating revenue. AAPC-certified coders experienced in ASC billing services and coding submit precise claims to help ASCS gain the highest FPAR. From patient registration until the ASC gets payment from patients and payers, Plutus Health creates a pathway for a smooth procedure. WASCA is a one-stop destination for ASCs to learn about the growth strategies of the business and coordinate with RCM billing services to gain solutions to all the huddles caused by the growth of their centers. You can visit their website to learn more about WASCA 2022. (Added: Wed Nov 02 2022 Hits: 30 Rating: 0.00 Votes: 0) Rate It

• senior care services ashoknagar - Our Nursing Services offer assistance in Senior Care (Eldercare), and the specific care and management of health conditions such as Stroke Rehabilitation and Recovery, Cancer, Parkinson’s Disease, and Diabetes. Our Physiotherapy services focus on pain management, whereas Caregiver (Aide) services provide bedside attendants and general caretakers that will offer professional help for the care and management of people recovering from surgery/injuries and for those suffering from long-term illnesses. Flat NO: #5E, Dutt's Island, Siripuram Junction, Ram Nagar, Visakhapatnam, Andhra Pradesh 530003. (Added: Wed Nov 02 2022 Hits: 31 Rating: 0.00 Votes: 0) Rate It

• Brain Stroke Treatment In Hyderabad, Brain Stroke Rehabilitation - Rehabilitation after a stroke is intended to assist you in retraining any abilities you may have lost as a result of the stroke that impacted a portion of your brain. Rehabilitation after a stroke can help you regain your independence and enhance your quality of life. https://curerehab.in/Brain-Stroke-Rehabilitation (Added: Wed Nov 02 2022 Hits: 40 Rating: 0.00 Votes: 0) Rate It

• Exosomes Gather Momentum in Targeted Delivery: Creative Biolabs Witnesses the Era - Creative Biolabs provides advanced analytics and exosome engineering solutions to drive exosomal targeting delivery studies. Exosomes, a type of cell-secreted nanoparticles, are important intercellular communicators. They bear diverse biological molecules such as nucleic acids, proteins, and lipids, which makes them promising platforms for targeted drug/gene delivery. Although being naturally stable, lowly immunogenic, and able to penetrate tissue/cell easily, the targeting ability and efficacy of exosomes as carriers might be limited by some factors in practical applications. To enhance the targeting ability of exosomes and overcome challenges in developing exosomal delivery systems, Creative Biolabs, the leading biotech company experienced in exosome research and manipulation, now combines exosomal delivery and targeting capabilities with sophisticated biomolecular engineering approaches to provide better exosome targeting solutions and support the development of exosome-based drug and vaccine delivery systems. Exosomes Targeting Based on Ligand-Receptor Binding Studies have shown that exosomes can express some lipids, cell adhesion molecules, and ligands targeting specific types of recipient cells. It means that exosomes can interact with target cells through the ligand-receptor binding on the surface and deliver an extensive range of molecules. Moreover, the exosome targeting capability can be achieved or even improved by engineering technologies. For instance, researchers have succeeded in loading Cas9 ribonucleoprotein (RNP) into purified exosomes derived from hepatocytes through electroporation to obtain a genome-editing delivery system to treat different liver disorders. Creative Biolabs provides a wide range of exosome engineering services to develop exosomes for targeting delivery, especially solutions to exosome targeting peptides. Exosome Display Techniques Displaying a ligand or a homing peptide specific to target recipient cells on the surface of exosomes is one of the most popular strategies for exosome targeting. Researchers at Creative Biolabs can display ligands/homing peptides on the surface of exosomal transmembrane proteins utilizing genetic engineering approaches. In addition, supplement services are also available, such as the identification of exosome targeting peptides and exosome reconstruction using different transmembrane proteins for fusion with specific ligands or homing peptides. Lentivirus Vector Reconstruction for Exosome Targeting The research team of Creative Biolabs has discovered an exosome targeting peptide for incorporation into cloning lentivectors. By reconstructing lentiviral vectors with exosome targeting components, lentivectors with multiple cloning sites will be able to fuse with interested proteins and deliver them to exosomes. In summary, exosomes are gathering strength in targeting delivery due to their properties of natural generation, nano-scaled size, low immunogenicity, and the ability to cross several biological barriers. However, the drawbacks of exosomal delivery systems are undeniable, including uncertain loading efficiency, rapid clearance from the systemic circulation, and weak targeting capacity in some cases. Creative Biolabs has been dedicated to providing exosome products and exploring multiple approaches to drive the development of exosome-based targeting delivery systems. For more information, check https://www.creative-biolabs.com/exosome/. About Creative Biolabs, headquartered in the United States, is a global contract research organization that provides comprehensive services and products for drug, vaccine, diagnostics development, and lifecycle management. The company has years of experience in exosome research and is broadly offering exosome-related services and products to global researchers to support both upstream and downstream applications of exosomes. (Added: Tue Nov 01 2022 Hits: 40 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... [>>]